Peptide 810, identified by the CAS number 156371-22-1, is a synthetic peptide that has garnered interest in various biochemical and pharmaceutical applications. Characteristically, it is composed of a specific sequence of amino acids, which contributes to its unique biological activity. Peptides like Peptide 810 often exhibit properties such as high specificity for certain receptors or enzymes, making them valuable in research and therapeutic contexts. They may also demonstrate stability under physiological conditions, although this can vary based on their structure and modifications. Additionally, Peptide 810 may have implications in areas such as drug development, particularly in targeting specific pathways or conditions. Its solubility, molecular weight, and potential interactions with other biomolecules are critical factors that influence its functionality. As with many peptides, understanding its mechanism of action and pharmacokinetics is essential for evaluating its efficacy and safety in potential applications.

Peptide 810

156371-22-1: Peptide 810, identified by the CAS number 156371-22-1, is a synthetic peptide that has garnered interest in various biochemical and pharmaceutical applications. Characteristically, it is composed of a specific sequence of amino acids, which contributes to its unique biological activity. Peptides like Peptide 810 often exhibit properties such as high specificity for certain receptors or enzymes, making them valuable in research and therapeutic contexts. They may also demonstrate stability under physiological conditions, although this can vary based on their structure and modifications. Additionally, Peptide 810 may have implications in areas such as drug development, particularly in targeting specific pathways or conditions. Its solubility, molecular weight, and potential interactions with other biomolecules are critical factors that influence its functionality. As with many peptides, understanding its mechanism of action and pharmacokinetics is essential for evaluating its efficacy and safety in potential applications.

<p>Peptide 810 is a growth factor that binds to the insulin receptor on the surface of cells. It has been shown to inhibit apoptosis in beta cells by binding to the insulin receptor and inhibiting phosphorylation of the insulin receptor at tyrosine residue 1135, thereby preventing apoptosis. This peptide also binds to other receptors, such as kinase and factor receptors, which are involved in regulating cell proliferation. Peptide 810 is secreted by recombinant proteins, and genetic analyses have shown that it is active against P. aeruginosa. It has also been used as a diagnostic tool for infectious diseases and has been used in assays for kinase receptors and factor receptors. The gene product of this peptide has been expressed in staphylococcus aureus cells, which have been tested as a vaccine against cancer.</p>

CAS 156371-22-1

Peptide 810

Peptide 810

Ref: 3D-FP108718